Moreover, the elevated expression of ICAM-1, IL-6, and IL-8 in tEV-treated HUVEC, suggest that EV may translocate these pro-inflammatory mediators and promote vascular endothelial inflammation. The gene discussed is CXCL8; the disease is inflammation.